159 related articles for article (PubMed ID: 31342138)
1. Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women.
Lewis JR; Brennan-Speranza TC; Levinger I; Byrnes E; Lim EM; Blekkenhorst LC; Sim M; Hodgson JM; Zhu K; Lim WH; Adams LA; Prince RL
Osteoporos Int; 2019 Oct; 30(10):2065-2072. PubMed ID: 31342138
[TBL] [Abstract][Full Text] [Related]
2. Reducing Undercarboxylated Osteocalcin With Vitamin K Supplementation Does Not Promote Lean Tissue Loss or Fat Gain Over 3 Years in Older Women and Men: A Randomized Controlled Trial.
Shea MK; Dawson-Hughes B; Gundberg CM; Booth SL
J Bone Miner Res; 2017 Feb; 32(2):243-249. PubMed ID: 27604070
[TBL] [Abstract][Full Text] [Related]
3. The effects of vitamin K-rich green leafy vegetables on bone metabolism: A 4-week randomised controlled trial in middle-aged and older individuals.
Sim M; Lewis JR; Prince RL; Levinger I; Brennan-Speranza TC; Palmer C; Bondonno CP; Bondonno NP; Devine A; Ward NC; Byrnes E; Schultz CJ; Woodman R; Croft K; Hodgson JM; Blekkenhorst LC
Bone Rep; 2020 Jun; 12():100274. PubMed ID: 32455149
[TBL] [Abstract][Full Text] [Related]
4. Undercarboxylated osteocalcin, muscle strength and indices of bone health in older women.
Levinger I; Scott D; Nicholson GC; Stuart AL; Duque G; McCorquodale T; Herrmann M; Ebeling PR; Sanders KM
Bone; 2014 Jul; 64():8-12. PubMed ID: 24662619
[TBL] [Abstract][Full Text] [Related]
5. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
[TBL] [Abstract][Full Text] [Related]
6. The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children.
van Summeren MJ; Braam LA; Lilien MR; Schurgers LJ; Kuis W; Vermeer C
Br J Nutr; 2009 Oct; 102(8):1171-8. PubMed ID: 19450370
[TBL] [Abstract][Full Text] [Related]
7. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc P; Chapuy MC; Meunier PJ; Delmas PD
J Clin Invest; 1993 Apr; 91(4):1769-74. PubMed ID: 8473517
[TBL] [Abstract][Full Text] [Related]
8. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men.
Yeap BB; Alfonso H; Chubb SA; Gauci R; Byrnes E; Beilby JP; Ebeling PR; Handelsman DJ; Allan CA; Grossmann M; Norman PE; Flicker L
J Clin Endocrinol Metab; 2015 Jan; 100(1):63-71. PubMed ID: 25365314
[TBL] [Abstract][Full Text] [Related]
9. Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus.
Kanazawa I; Tanaka K; Ogawa N; Yamauchi M; Yamaguchi T; Sugimoto T
Osteoporos Int; 2013 Mar; 24(3):1115-9. PubMed ID: 22669468
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture.
Liu G; Peacock M
Calcif Tissue Int; 1998 Apr; 62(4):286-9. PubMed ID: 9504950
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-vitamin K interaction: effect of vitamin D supplementation on serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, in Danish girls.
O'Connor E; Mølgaard C; Michaelsen KF; Jakobsen J; Cashman KD
Br J Nutr; 2010 Oct; 104(8):1091-5. PubMed ID: 20487587
[TBL] [Abstract][Full Text] [Related]
12. Association of vitamin K status with adiponectin and body composition in healthy subjects: uncarboxylated osteocalcin is not associated with fat mass and body weight.
Knapen MH; Schurgers LJ; Shearer MJ; Newman P; Theuwissen E; Vermeer C
Br J Nutr; 2012 Sep; 108(6):1017-24. PubMed ID: 22136751
[TBL] [Abstract][Full Text] [Related]
13. The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial.
Rasekhi H; Karandish M; Jalali MT; Mohammad-Shahi M; Zarei M; Saki A; Shahbazian H
Eur J Clin Nutr; 2015 Aug; 69(8):891-5. PubMed ID: 25782427
[TBL] [Abstract][Full Text] [Related]
14. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamauchi M; Yamamoto M; Kurioka S; Yano S; Sugimoto T
Osteoporos Int; 2011 Jan; 22(1):187-94. PubMed ID: 20165834
[TBL] [Abstract][Full Text] [Related]
15. Osteocalcin and measures of adiposity: a systematic review and meta-analysis of observational studies.
Liu X; Liu Y; Mathers J; Cameron M; Levinger I; Yeap BB; Lewis JR; Brock KE; Brennan-Speranza TC
Arch Osteoporos; 2020 Sep; 15(1):145. PubMed ID: 32945990
[TBL] [Abstract][Full Text] [Related]
16. Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women.
Kim SM; Kim KM; Kim BT; Joo NS; Kim KN; Lee DJ
J Korean Med Sci; 2010 Aug; 25(8):1171-5. PubMed ID: 20676328
[TBL] [Abstract][Full Text] [Related]
17. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study.
Iki M; Tamaki J; Fujita Y; Kouda K; Yura A; Kadowaki E; Sato Y; Moon JS; Tomioka K; Okamoto N; Kurumatani N
Osteoporos Int; 2012 Feb; 23(2):761-70. PubMed ID: 21437719
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcium, vitamins K1 and D3 on bone in galactosemia.
Panis B; Vermeer C; van Kroonenburgh MJPG; Nieman FHM; Menheere PPCA; Spaapen LJ; Rubio-Gozalbo ME
Bone; 2006 Nov; 39(5):1123-1129. PubMed ID: 16782422
[TBL] [Abstract][Full Text] [Related]
19. The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS).
Furusyo N; Ihara T; Hayashi T; Ikezaki H; Toyoda K; Ogawa E; Okada K; Kainuma M; Murata M; Hayashi J
Endocrine; 2013 Jun; 43(3):635-42. PubMed ID: 23001602
[TBL] [Abstract][Full Text] [Related]
20. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).
Schafer AL; Sellmeyer DE; Schwartz AV; Rosen CJ; Vittinghoff E; Palermo L; Bilezikian JP; Shoback DM; Black DM
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1982-9. PubMed ID: 21994958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
